Dermatology logo

Case Studies:

Diagnosis of Atopic Dermatitis in Adults

The diagnosis of this condition is often not straight-forward and several other conditions have to be considered in the differential diagnosis (See below). Where the disease represents mere continuation of atopic dermatitis from childhood, the diagnosis is usually easy and the clinical picture also typical. Difficulty arises where onset occurs after the age of 18 years (adult-onset atopic dermatitis) and in these cases the disease pattern is often not obvious, although it may still present with the usual flexural dermatitis seen in children. Non-typical morphology and localization are common with nummular, prurigo-like, follicular and seborrheic patterns often seen . Erythroderma is a rare manifestation of atopic dermatitis in adults . The physical and environmental factors at play in adults differ from that in children and this is responsible for the different patterns of involvement.

The time-honoured criteria set out by Hanifin and Rajka have come under severe criticism over the past decade or two and these criteria are even more unreliable when applied to adult cases. A revised set of criteria was developed by Williams et al and this was validated in the hospital setting and in the community . It is the opinion of this work group that these criteria should be adopted for the diagnosis of atopic dermatitis in adults in South Africa, even though a recent study has shown that these criteria are not reliable when applied in the low prevalence, rural areas of the Eastern Cape, a study done on children.

These criteria are set out in the following:

The diagnosis of atopic dermatitis in adults is primarily clinical; special investigations only contribute in identifying external aggravating factors

Revised Criteria for the Diagnosis of Atopic Dermatitis1:
  1. Must have:
    • Pruritus
  2. Plus three or more of the following:
    • History of involvement of skin creases (front of elbows, back of knees, front of ankles, neck, around the eyes)
    • History of a generally dry skin in the past year
    • Personal history of asthma or hay fever
    • Onset under the age of two years
    • Visible flexural dermatitis
The histological findings on skin biopsy can be suggestive of the diagnosis, but on the whole it is not helpful and cannot be relied upon to make the diagnosis1.

Total IgE-levels are significantly raised in about 80% of cases, being normal in the rest, therefore reducing the value thereof in the diagnosis. The level of IgE does not correlate with severity of the dermatitis and 15% of non-atopic individuals have raised IgE levels.

Several conditions have to be considered in the differential diagnosis of AD in adults, as listed in the next table. These have to be excluded on clinical grounds and by employing appropriate investigations.

Differential diagnosis of atopic dermatitis in adults:
  • Seborrheic dermatitis
  • Discoid (nummular) dermatitis
  • Irritant contact dermatitis (especially of the hands
  • Allergic contact dermatitis and airborne contact dermatitis
  • Photo-allergic and photo-irritant dermatitis
  • “HIV-dermatitis”
  • Drug-induced dermatitis
  • Cutaneous T-cell lymphoma
  • Psoriasis, especially the erythrodermic type
  • Scabies
  • Insect bites
  • Filariasis
Measuring the severity of atopic dermatitis

The severity of dermatitis in individual cases can be measured and monitored in several ways. The SCORAD index (SCOring Atopic Dermatitis) uses clinical parameters developed by the European Task Force on Atopic Dermatitis (1990-92) where a patient is compared to a set of standard colour photographs and parameters are scored on an easy to use computer programme, which assigns a numerical value to the severity of the dermatitis at that point in time.

The Objective Severity Assessment of Atopic Dermatitis (OSAAD) score utilizes non-invasive bioengineering methods and computer-assisted estimates of disease extent to measure transepidermal water loss, stratum corneum hydration and affected body surface. A numerical score is then produced to denote severity. The reliability and sensitivity of this test in adult patients have been confirmed recently , when it was compared with SCORAD and it also significantly correlated with serum levels of Interleukin-16, which seems to be a sensitive and reliable marker of disease activity in atopic dermatitis , also in adults.

The Three Item Severity score only utilizes excoriations, erythema and papulation / vesiculation as parameters and best reflects the severity of dermatitis from the patient’s point of view. This is also far more practical for use in clinical practice.

It is the opinion of this panel that the severity assessment should be simplified to make it easy to use in practice. The aim is to stratify treatment accordingly in individual patients. We propose:
  1. A measurement of the area involved in percentage of body surface, where 1% body surface is equal to the size of one hand of the patient
  2. Acute, subacute or chronic changes, where acute changes would imply more severe dermatitis. These changes have been explained under the heading of definitions.
  3. Impact on the quality of life of the patient, as measured by sleep disturbance, absenteeism, visible scratching, social withdrawal, etc., according to the judgment of the clinician managing the case.
Dermatitis can then be classified as mild, moderate or severe as outlined in the next table. Stratification of treatment according to this scheme will be explained below.

A flare of dermatitis can be defined as any episode of “upgrading” of the dermatitis from one group to the next, e.g. mild to moderate.
Severity of Atopic Dermatitis:
  • Mild: Less than 5% body surface involved
      No acute changes
      No significant impact on quality of life
  • Moderate: 5 – 30% body surface involved
      Mild dermatitis with acute changes
      Mild dermatitis with significant impact on quality of life
  • Severe: More than 30% body surface involved
      Moderate dermatitis with acute changes
      Moderate dermatitis with significant impact on quality of life


  1. Ozkaya E. Adult-onset atopic dermatitis. J Am Acad Dermatol 2005;52:579-82
  2. Rym BM, Mourad M, Bechir Z, Dalenda E, Faika C, Iadh AM, Amel BO. Erythroderma in adults: a report of 80 cases. Int J Dermatol 2005;44(9):731-5
  3. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh) 1980;(Suppl 92):44-7
  4. Williams HC, Burney PG, Hay RJ et al. The U.K. Working Party’s diagnostic criteria for atopic dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis. Br J Dermatol 1994;131:383-96
  5. Williams HC, Burney PG, Pembroke AC, Hay RJ. The U.K. Working Party’s diagnostic criteria for atopic dermatitis. III. Independent hospital validation. Br J Dermatol 1994;131:406-16
  6. Williams HC, Burney PG, Strachan D, Hay RJ. The U.K. Working Party’s diagnostic criteria for atopic dermatitis. II. Observer variation of clinical diagnosis and signs of atopic dermatitis. Br J Dermatol 1994;131:397-405
  7. Chalmers DA, Todd G, Saxe N, et al. Validation of the U.K. Working Party diagnostic criteria for atopic eczema in a Xhoza-speaking African population. Br J Dermatol 2007;156(1):111-6
  8. Severity scoring of atopic dermatitis. The SCORAD index: Consensus report of the European Task Force on Atopic Dermatitis. Dermatology 1993;186:23-31
  9. Sugarman J, Fluhr J, Fowler A, et al. The Objective Severity Assessment Atopic Dermatitis score. Arch Dermatol 2003;139:1417-22
  10. Angelova-Fischer I, Bauer A, Hipler UC, et al. The Objective Severity Assessment of Atopic Dermatitis (OSAAD) score: validity, reliability and sensitivity in adult patients with atopic dermatitis. Br J Dermatol 2005;153:767-73
  11. Frezzolini A, Paradisi M, Faffiro A, et al. Circulating interleukin-16 (Il-16) in children with atopic eczema/dermatitis syndrome (AEDS): a novel marker of disease activity. Acta Derm Venereol 2002;57:815-20
  12. Masuda K, Katoh N, Okuda F, Kishimoto S. Increased levels of serum interleukin-16 in adult type atopic dermatitis. Acta Derm Venereol 2003;83:49-53
  13. Charman CR, Venn AJ, Williams HC. Measuring atopic eczema severity visually: which variables are most important to patients? Arch Dermatol 2005;141(9):1146-51

GALDERMA
Copyright 2012 Dermatology | Website terms of use | Privacy Policy Admin
Powered By
E2